Improved renal function in diabetic patients with acute gout treated with anakinra

Kidney International

Volumn 88, Issue 1, 2015, Pages 195-196

  Balasubramaniam, Gowrie ^a   Almond, Michael ^a   Dasgupta, Bhaskar ^a  

^a SOUTHEND UNIVERSITY HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

INFLAMMASOME; RECOMBINANT INTERLEUKIN 1 RECEPTOR BLOCKING AGENT; CARRIER PROTEIN;

ACUTE GOUT; CHRONIC KIDNEY DISEASE; DIABETES MELLITUS; DISEASE SEVERITY; DRUG EFFICACY; GOUT; HUMAN; HYPERURICEMIA; KIDNEY CLEARANCE; KIDNEY FUNCTION; LETTER; NONHUMAN; PRIORITY JOURNAL; ANIMAL; CYTOLOGY; DIABETIC NEPHROPATHY; GLOMERULUS; IMMUNOLOGY;

ANIMALS; CARRIER PROTEINS; DIABETIC NEPHROPATHIES; HUMANS; INFLAMMASOMES; KIDNEY GLOMERULUS;

EID: 84934287834     PISSN: 00852538     EISSN: 15231755     Source Type: Journal    
DOI: 10.1038/ki.2015.125     Document Type: Letter

References (5)

1. Balasubramaniam G, Almond M, Dasgupta B. Improved renal function in diabetic patients with acute gout treated with anakinra. Kidney Int 2015; 88: 195-196.
2. Larsen CM, Faulenbach M, Vaag A et al. Interleukin-1-receptor antagonist in type 2 diabetes mellitus. N Engl J Med 2007; 356: 1517-1526.
3. Shahzad K, Bock F, Dong W et al. Nlrp3-inflammasome activation in nonmyeloid-derived cells aggravates diabetic nephropathy. Kidney Int 2015; 87: 74-84.
4. Gupta J, Mitra N, Kanetsky PA et al. Association between albuminuria, kidney function, and inflammatory biomarker profile in CKD in CRIC. Clin J Am Soc Nephrol 2012; 7: 1938-1946.
5. de Luca A, Smeekens SP, Casagrande A et al. IL-1 receptor blockade restores autophagy and reduces inflammation in chronic granulomatous disease in mice and in humans. Proc Natl Acad Sci USA 2014; 111: 3526-3531.